Complera (Emtricitabine, Rilpivirine and Tenofovir Disoproxil)
Emtricitabine, Rilpivirine and Tenofovir Disoproxil comes in 3 pill versions in our database, in 2 strengths, from 3 manufacturers. Check the imprint to tell them apart.
Emtricitabine, Rilpivirine and Tenofovir Disoproxil pill images
25 mg / 200 mg / 300 mg 1 pill
200 mg / 25 mg / 300 mg 2 pills
What is Emtricitabine, Rilpivirine and Tenofovir Disoproxil used for?
Emtricitabine, Rilpivirine and Tenofovir Disoproxil is used for HIV.
- Medicine type
- HIV medicine
Official uses from the US prescribing label
Emtricitabine, rilpivirine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg:
- as initial therapy in those with no antiretroviral treatment history with HIV-1 RNA less than or equal to 100,000 copies/mL at the start of therapy or
- to replace a stable antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen for at least 6 months with no treatment failure and no known substitutions associated with resistance to the individual components of emtricitabine, rilpivirine and tenofovir disoproxil fumarate tablets.
Limitations of Use:
- More rilpivirine-treated subjects with HIV-1 RNA greater than 100,000 copies/mL at the start of therapy experienced virologic failure (HIV-1 RNA ≥ 50 copies/mL) compared to rilpivirine-treated subjects with HIV-1 RNA less than or equal to 100,000 copies/mL.
From the FDA-approved label on DailyMed (published May 30, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.